The first child in history has successfully been treated with a new genetic therapy for an ultra-rare developmental defect ...

To discover more about Nature’s Fynd, visit. To learn about their remarkable nutritional fungi protein and fermentation ...

Epigenetic regulation plays a central role in shaping the molecular landscape of cancer. Beyond permanent genetic mutations, epigenetic changes provide a ...

ESKAPE infections generally require extensive treatment procedures. Every ESKAPE pathogen has a wide range of infection and pathogenesis mechanisms, which has resulted in the development of resistance ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

Learn more about whether Immunocore Holdings plc or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Born in Morristown, N.J., with virtually no immune system, Cora was diagnosed with severe combined immunodeficiency, a rare ...

A recently approved group of drugs - immune checkpoint inhibitors - can boost the body's ability to eliminate a tumor and ...

The successful gene therapy is AMT-130, developed by a company called UniQure. In a three-year trial of 29 participants with ...

The biological world is always expanding as research is constantly being done. Because of this, many findings often fall ...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...

Oliver Chu is one of five kids participating in a clinical trial investigating a gene therapy for Hunter syndrome, a disorder with symptoms akin to childhood dementia that limits life expectancy ...